Swine Porcine Reproductive and Respiratory Syndrome: Diagnosis and Management
Porcine reproductive and respiratory syndrome (PRRS) is a viral disease of swine caused by an arterivirus that produces reproductive failure in breeding herds and respiratory disease in growing pigs. This article provides veterinarians and swine health professionals with syndrome-level investigation guidance covering clinical recognition, diagnostic methods including PCR and ELISA, vaccination strategies, biosecurity measures, and herd closure protocols. The content is based on published veterinary literature and official animal health organization resources.
At a Glance
| Clinical Presentation | Affected Population | Primary Diagnostic Approach | Management Consideration |
|---|---|---|---|
| Reproductive failure: late-term abortions, mummies, stillbirths, weak-born piglets | Breeding females, especially gilts and sows in first trimester | Serum PCR, ELISA serology, tissue PCR from aborted fetuses | Herd closure, acclimation protocols, vaccination timing |
| Respiratory disease: fever, dyspnea, tachypnea, increased mortality | Nursery and grow-finish pigs, especially 3-8 weeks of age | Oral fluid PCR, serum PCR, lung tissue PCR at necropsy | Flow management, all-in/all-out production, vaccination |
| Persistent infection and viral shedding | All ages, with prolonged viremia in young pigs | Serial PCR testing over 4-8 weeks | Elimination protocols, depopulation/repopulation decisions |
| Subclinical infection with production losses | Endemically infected herds with stable immunity | Monthly production record analysis, ELISA monitoring | Vaccination program review, biosecurity audit |
Clinical Recognition and Syndrome Investigation
PRRS virus infection produces a spectrum of clinical signs that vary by virus strain, host immune status, age, and production system. The World Organisation for Animal Health (WOAH) recognizes PRRS as a significant transboundary animal disease requiring official reporting in many regions. The Merck Veterinary Manual describes PRRS as one of the most economically important diseases affecting swine production worldwide.
Reproductive Syndrome in Breeding Herds
The reproductive form of PRRS typically appears as an outbreak of late-term reproductive failure. Affected sows and gilts may show transient anorexia, fever, and lethargy 1-2 weeks before abortion storms begin. Abortions usually occur in the last third of gestation, with fetuses showing autolysis and mummification at varying stages. Stillbirth rates increase sharply, and live-born piglets are often weak, with high preweaning mortality.
Veterinarians investigating reproductive outbreaks should collect the following clinical observations:
- Abortion rate exceeding 2-3% per week in previously stable herds
- Increased return-to-service intervals
- Delayed farrowing or prolonged farrowing duration
- Increased mummy and stillborn counts per litter
- Weak piglets with splay-leg appearance or respiratory distress at birth
The reproductive syndrome results from viral replication in fetal tissues and the placenta, causing vascular damage and fetal death. The severity of reproductive losses correlates with the stage of gestation at infection, with first-trimester infections causing the most severe losses.
Respiratory Syndrome in Growing Pigs
Respiratory disease from PRRS virus is most pronounced in nursery and early grow-finish pigs. Clinical signs include fever (104-107°F), tachypnea, dyspnea, lethargy, and reduced feed intake. Mortality rates can reach 10-15% in severe outbreaks, particularly when secondary bacterial infections occur.
Common observations during respiratory outbreaks include:
- Acute onset of respiratory signs in pigs 3-8 weeks of age
- Coughing, thumping, and abdominal breathing
- Rough hair coats and poor growth rates
- Increased mortality, especially from secondary bacterial pneumonia
- Variable response to antimicrobial therapy
The respiratory syndrome is complicated by PRRS virus-induced immunosuppression, which predisposes pigs to secondary infections with agents such as Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Streptococcus suis, and Salmonella species. Coinfections significantly worsen clinical outcomes and increase diagnostic complexity.
Subclinical and Chronic Infection
Many PRRS virus infections are subclinical, particularly in herds with endemic infection and stable immunity. These herds may show no obvious clinical signs but experience reduced reproductive performance, increased preweaning mortality, and decreased growth rates. Chronic infection is characterized by persistent viral shedding from infected pigs, which maintains transmission within the herd.
Veterinarians should suspect subclinical PRRS when production records show:
- Gradual decline in farrowing rate over 3-6 months
- Increased preweaning mortality without obvious cause
- Reduced average daily gain in nursery pigs
- Increased medication costs for respiratory disease
- Variable response to vaccination programs
Diagnostic Methods
Accurate diagnosis of PRRS requires laboratory confirmation using appropriate sample types and testing methods. The choice of diagnostic test depends on the clinical presentation, stage of infection, and purpose of testing (initial diagnosis, monitoring, or elimination verification).
PCR Testing
Polymerase chain reaction (PCR) is the primary method for detecting PRRS virus RNA in clinical samples. PCR testing is highly sensitive and specific, allowing detection of virus before seroconversion and in persistently infected animals. The Merck Veterinary Manual notes that PCR can detect PRRS virus in serum, oral fluids, semen, and tissues.
Sample types and their applications include:
- Serum: Best for individual pig diagnosis, especially in acute infections. Collect from febrile, lethargic pigs in the first 7-10 days of clinical signs.
- Oral fluids: Useful for group-level surveillance in nursery and grow-finish populations. Rope samples from 20-30 pigs per pen provide herd-level sensitivity.
- Tissue: Lung, tonsil, lymph node, and spleen from necropsied pigs. Lung tissue is preferred for respiratory cases, fetal tissues for reproductive cases.
- Semen: Required for boar stud monitoring. PRRS virus can be shed in semen for extended periods.
PCR testing can differentiate between PRRS virus genotypes (Type 1, European, Type 2, North American) and can be used for sequencing to track virus movement and identify novel strains. Quantitative PCR (qPCR) provides viral load information that can help assess infection severity and response to intervention.
ELISA Serology
Enzyme-linked immunosorbent assay (ELISA) detects antibodies against PRRS virus, indicating prior exposure or vaccination. ELISA testing is used for herd-level surveillance, monitoring vaccination response, and verifying negative status in naive populations.
Key considerations for ELISA interpretation include:
- Timing: Antibodies appear 7-14 days post-infection and persist for months to years. Acute infections may be ELISA-negative if sampled before seroconversion.
- Maternal antibodies: Piglets from immune sows have passive antibodies that can persist for 4-8 weeks, complicating interpretation in young pigs.
- Vaccination history: Modified-live virus (MLV) vaccines produce antibody responses indistinguishable from natural infection. Differentiating infected from vaccinated animals (DIVA) is not possible with standard ELISA.
- Cutoff values: Laboratories use standardized cutoff values, but herd-specific baselines may improve interpretation.
ELISA results are reported as sample-to-positive (S/P) ratios. Higher S/P ratios generally indicate more recent or stronger immune responses, but correlation with protection is imperfect.
Virus Isolation and Sequencing
Virus isolation in cell culture is the gold standard for confirming infectious virus but is slower and less sensitive than PCR. Sequencing of PRRS virus isolates provides information on genetic relatedness between strains, which is valuable for outbreak investigations and understanding virus movement.
Sequencing targets include:
- ORF5: Most commonly sequenced region, encoding the major envelope glycoprotein. Used for phylogenetic analysis and strain typing.
- ORF7: Nucleocapsid gene, highly conserved. Useful for genotyping.
- Whole genome sequencing: Provides maximum resolution for outbreak investigations and research.
The World Organisation for Animal Health recommends sequencing for epidemiological investigations and to monitor for emergence of novel strains.
Necropsy and Histopathology
Necropsy examination provides gross and microscopic evidence of PRRS virus infection. Typical findings include:
- Lungs: Interstitial pneumonia with failure to collapse, mottled tan-to-purple appearance, and interlobular edema. Microscopically, septal thickening with mononuclear cell infiltration.
- Lymph nodes: Enlargement, particularly inguinal and bronchial nodes. Follicular hyperplasia and lymphoid depletion.
- Reproductive tract: Placentitis, fetal autolysis, and endometrial hemorrhage in sows with reproductive failure.
- Brain: Nonsuppurative encephalitis in some strains, particularly in young pigs.
Histopathology is supportive but not definitive for PRRS diagnosis. Confirmation requires PCR or virus isolation.
Sample Collection and Submission
Proper sample collection and handling are essential for accurate diagnostic results. Veterinarians should establish protocols for sample collection, storage, and shipping.
Sample Collection Protocols
For reproductive outbreaks:
- Collect serum from 5-10 affected sows or gilts (acutely febrile animals preferred)
- Collect fetal tissues (lung, thymus, thoracic fluid) from 3-5 aborted fetuses
- Collect placenta from affected sows
- Collect stillborn piglet tissues (lung, spleen, lymph node)
- Collect serum from weak-born piglets before colostrum intake if possible
For respiratory outbreaks:
- Collect serum from 10-20 acutely ill pigs (febrile, dyspneic, untreated)
- Collect oral fluids from affected pens (1 rope per 20-30 pigs)
- Necropsy 3-5 acutely ill or recently dead pigs, collecting lung, tonsil, lymph node, and spleen
- Collect lung lavage fluid if available
For herd monitoring:
- Collect serum from 30 pigs per production stage (breeding, farrowing, nursery, grow-finish)
- Collect oral fluids from 10 pens per production stage
- Collect processing fluids (testicles, tails) from newborn piglets for sow herd monitoring
Sample Handling and Shipping
PRRS virus is relatively labile and requires proper handling to maintain viability for PCR and virus isolation. Key considerations include:
- Collect samples aseptically to minimize contamination
- Refrigerate samples immediately (4°C) for PCR testing
- Freeze samples (-20°C or -80°C) for virus isolation or if shipping will be delayed
- Ship samples on ice packs via overnight courier
- Use leak-proof containers and absorbent material
- Label samples clearly with farm identification, date, and sample type
- Include submission form with clinical history and testing requested
Vaccination Strategies
Vaccination is a cornerstone of PRRS control in many herds, but vaccine efficacy varies by strain, timing, and herd status. Both modified-live virus (MLV) and killed virus (KV) vaccines are available, each with advantages and limitations.
Modified-Live Virus Vaccines
MLV vaccines contain live, attenuated PRRS virus that replicates in the host and induces both humoral and cell-mediated immunity. The Merck Veterinary Manual notes that MLV vaccines provide partial protection against heterologous strains and good protection against homologous strains.
Advantages of MLV vaccines:
- Induce broader immunity than killed vaccines
- Provide some cross-protection against different strains
- Can be used in growing pigs and breeding animals
- Reduce shedding and transmission in vaccinated populations
Limitations of MLV vaccines:
- May cause viremia and shedding in vaccinated pigs
- Can revert to virulence in some circumstances
- Do not prevent infection with heterologous strains
- May interfere with diagnostic testing (cannot differentiate vaccine from field virus)
- Require careful timing in breeding herds to avoid reproductive effects
Killed Virus Vaccines
KV vaccines contain inactivated PRRS virus and are considered safer but less immunogenic than MLV vaccines. They are typically used in breeding herds for booster vaccination.
Advantages of KV vaccines:
- No risk of reversion to virulence
- Safe for use in pregnant sows and gilts
- Can be used in PRRS-negative herds without introducing live virus
- May be combined with other antigens
Limitations of KV vaccines:
- Induce weaker immune responses than MLV vaccines
- Require multiple doses for adequate protection
- Provide limited cross-protection against heterologous strains
- Less effective in reducing shedding and transmission
Vaccination Protocols
Vaccination protocols should be tailored to herd status, production system, and circulating virus strains. Common protocols include:
For breeding herds:
- Whole-herd vaccination: All breeding animals vaccinated with MLV vaccine, followed by regular booster vaccination every 3-4 months
- Gilt acclimation: Gilts vaccinated 2-3 times before first breeding, with exposure to field virus if possible
- Pre-farrowing boost: Sows vaccinated 2-4 weeks before farrowing to boost maternal antibody transfer
For growing pigs:
- Nursery vaccination: Pigs vaccinated at 2-4 weeks of age, before expected exposure
- Single or double dose: Some protocols use two doses 2-4 weeks apart for improved protection
- Timing relative to weaning: Vaccination at weaning or 1-2 weeks post-weaning
The decision to vaccinate should consider:
- Herd PRRS status (naive, unstable, stable, or negative)
- Circulating virus strains and their relatedness to vaccine strains
- Production system and pig flow
- Economic analysis of vaccination costs versus disease losses
- Regulatory requirements and export considerations
Vaccine Selection and Monitoring
Vaccine selection should be based on:
- Strain match between vaccine and field virus (homologous protection is strongest)
- Safety profile in the target population
- Compatibility with existing vaccination programs
- Cost-effectiveness analysis
Monitoring vaccine effectiveness includes:
- Serological monitoring of antibody responses post-vaccination
- Production record analysis comparing pre- and post-vaccination performance
- PCR monitoring of shedding in vaccinated populations
- Clinical surveillance for breakthrough disease
Biosecurity Measures
Biosecurity is essential for preventing PRRS virus introduction and controlling spread within and between herds. The World Organisation for Animal Health emphasizes biosecurity as a key component of PRRS control programs.
External Biosecurity
External biosecurity measures prevent introduction of PRRS virus into naive herds. Key components include:
Quarantine and acclimation: New breeding stock should be quarantined for 30-60 days and tested for PRRS virus before introduction. Acclimation protocols expose incoming animals to resident herd pathogens in a controlled manner.
Transport biosecurity: Livestock trailers are a major vector for PRRS virus transmission. Protocols should include:
- Cleaning and disinfection between loads
- Dedicated trailers for PRRS-negative herds
- Driver training on biosecurity procedures
- Loading area management to prevent contamination
Feed and supply biosecurity: PRRS virus can survive in feed ingredients and on fomites. Measures include:
- Sourcing feed from PRRS-negative suppliers
- Feed storage and handling protocols
- Disinfection of incoming supplies and equipment
- Boot and clothing changes for visitors
Personnel and visitor protocols: People can carry PRRS virus on clothing, boots, and equipment. Requirements include:
- Shower-in/shower-out facilities
- Farm-specific clothing and boots
- Visitor log and health declaration
- Downtime requirements (24-48 hours) for people with pig contact
Airborne transmission: PRRS virus can travel short distances through the air, particularly in cold, humid conditions. Measures to reduce airborne risk include:
- Site selection with adequate separation from other pig farms
- Air filtration systems in high-risk areas
- Windbreak fences or vegetation barriers
- Reduced pig density in high-risk regions
Internal Biosecurity
Internal biosecurity measures control spread of PRRS virus within a herd. Key components include:
Pig flow management: All-in/all-out production by room or barn reduces PRRS virus transmission between age groups. Continuous flow systems increase the risk of persistent infection.
Ventilation and airspace management: Separate ventilation systems for different production stages prevent airborne transmission within facilities. Positive pressure ventilation can reduce entry of contaminated air.
Equipment and tool management: Dedicated equipment for each production stage prevents fomite transmission. Disinfection protocols for shared equipment are essential.
Needle and injection protocols: PRRS virus can be transmitted through contaminated needles. Single-use needles or needle changes between litters reduce this risk.
Manure and waste management: PRRS virus can survive in manure for short periods. Proper manure handling and disposal protocols reduce environmental contamination.
Biosecurity Audits and Monitoring
Regular biosecurity audits identify gaps and measure compliance. Components include:
- Written biosecurity protocols for all personnel
- Training records and competency assessments
- Compliance monitoring through observation and record review
- Risk assessment for each potential introduction route
- Corrective action plans for identified deficiencies
Herd Closure Protocols
Herd closure is a strategy for eliminating PRRS virus from breeding herds without depopulation. The protocol involves stopping introduction of new breeding stock for a defined period, allowing the existing herd to develop immunity and clear the virus.
Principles of Herd Closure
Herd closure works by:
- Removing the source of new susceptible animals
- Allowing time for all animals to be exposed and develop immunity
- Reducing viral shedding as immunity develops
- Breaking the transmission cycle within the breeding herd
The Merck Veterinary Manual describes herd closure as an effective strategy for PRRS elimination in breeding herds, particularly when combined with vaccination and biosecurity measures.
Implementation Protocol
Phase 1: Preparation (4-8 weeks)
- Stabilize the herd through vaccination and biosecurity improvements
- Test all breeding animals to establish baseline PRRS status
- Identify and cull chronically infected or non-productive animals
- Develop a timeline for closure and reopening
- Communicate the plan to all personnel
Phase 2: Closure (16-32 weeks)
- Stop introduction of all new breeding stock
- Vaccinate all breeding animals with MLV vaccine (if not already immune)
- Implement enhanced biosecurity to prevent reintroduction
- Monitor viral shedding through regular testing (serum, oral fluids)
- Track production parameters to assess stabilization
Phase 3: Stabilization monitoring
- Test all breeding animals for PRRS virus at 8-12 week intervals
- Monitor farrowing rates, abortion rates, and preweaning mortality
- Test piglets at weaning to confirm absence of vertical transmission
- Continue biosecurity measures throughout closure period
Phase 4: Reopening (after stabilization confirmed)
- Introduce negative replacement gilts from PRRS-negative sources
- Continue quarantine and acclimation protocols
- Maintain enhanced biosecurity
- Monitor for reintroduction of PRRS virus
Duration and Success Factors
The duration of herd closure depends on:
- Herd size and turnover rate
- Initial PRRS virus prevalence
- Effectiveness of biosecurity measures
- Vaccination status and immune response
Typical closure periods range from 16-32 weeks, with larger herds requiring longer closure. Success factors include:
- Strict compliance with closure protocols
- Effective biosecurity to prevent reintroduction
- Adequate vaccination coverage
- Removal of persistently infected animals
- Monitoring to confirm elimination
Limitations and Risks
Herd closure is not appropriate for all herds. Limitations include:
- Genetic progress is delayed during closure
- Replacement gilt supply may be disrupted
- Large herds may require extended closure periods
- Some herds may not achieve elimination
- Reintroduction risk remains after reopening
Records and Measurements
Systematic record keeping is essential for PRRS diagnosis, management, and elimination. Production records provide the basis for detecting outbreaks, monitoring response to interventions, and verifying elimination.
Production Records
Key production parameters for PRRS monitoring include:
- Farrowing rate: Percentage of mated females that farrow. PRRS reduces farrowing rate by 5-20%.
- Abortion rate: Percentage of pregnant females that abort. PRRS outbreaks cause abortion rates exceeding 5% per week.
- Litter size: Total born, born alive, stillborn, and mummies per litter. PRRS reduces live-born piglets by 1-3 per litter.
- Preweaning mortality: Percentage of live-born piglets that die before weaning. PRRS increases preweaning mortality by 5-15%.
- Weaning weight: Average piglet weight at weaning. PRRS reduces weaning weights by 0.5-1.5 kg.
- Nursery mortality: Percentage of weaned pigs that die in the nursery. PRRS increases nursery mortality by 5-20%.
- Average daily gain: Growth rate in nursery and grow-finish. PRRS reduces ADG by 10-30%.
- Feed conversion ratio: Feed efficiency. PRRS increases FCR by 5-15%.
Diagnostic Records
Maintain records of all diagnostic testing, including:
- Sample collection dates and locations
- Test types and results (PCR, ELISA, sequencing)
- Laboratory and test methods used
- Interpretation and action taken
- Trends over time
Vaccination Records
Document all vaccination activities:
- Vaccine type, lot number, and expiration date
- Date and route of administration
- Target population and number of animals vaccinated
- Adverse reactions or complications
- Booster schedule and compliance
Biosecurity Records
Track biosecurity compliance:
- Visitor logs and health declarations
- Quarantine and acclimation records
- Cleaning and disinfection logs
- Transport and feed biosecurity records
- Biosecurity audit results
Common Failure Patterns
Understanding common failures in PRRS diagnosis and management helps veterinarians avoid mistakes and improve outcomes.
Diagnostic Failures
Inappropriate sample selection: Collecting samples from chronic or recovered animals instead of acutely ill pigs reduces diagnostic sensitivity. Always sample febrile, untreated animals in the first 7-10 days of clinical signs.
Inadequate sample size: Testing too few animals misses low-prevalence infections. For herd-level detection, sample size calculations should account for expected prevalence and desired confidence level.
Poor sample handling: Delayed shipping, improper temperature, or contamination degrades sample quality and reduces test sensitivity. Follow laboratory guidelines for sample collection and shipping.
Testing too early or too late: PCR testing after 14-21 days of infection may be negative as viremia resolves. ELISA testing before 7-14 days may be negative before seroconversion. Match test timing to the stage of infection.
Misinterpretation of results: Positive PCR results may reflect vaccine virus instead of field virus. Negative ELISA results in vaccinated pigs may reflect waning antibody levels instead of lack of protection.
Management Failures
Incomplete biosecurity: Focusing on one transmission route while ignoring others allows continued virus introduction. All routes (pig movement, transport, personnel, fomites, air) must be addressed.
Inconsistent vaccination: Missed doses, improper storage, or incorrect administration reduces vaccine effectiveness. Vaccination protocols must be followed precisely.
Inadequate herd closure: Premature reopening or incomplete compliance with closure protocols prevents elimination. Closure must be maintained until stabilization is confirmed.
Failure to address co-infections: PRRS virus infection is often complicated by other pathogens. Managing PRRS without addressing concurrent infections leads to continued disease.
Poor communication: Lack of communication between farm staff, veterinarians, and management leads to inconsistent implementation of protocols. Regular meetings and clear documentation are essential.
Elimination Failures
Reintroduction from external sources: Failure to maintain biosecurity after elimination allows reintroduction. Ongoing biosecurity is essential for maintaining PRRS-negative status.
Persistent infection in breeding herd: Some animals may remain persistently infected despite herd closure. Testing and culling of positive animals may be necessary.
Inadequate duration of closure: Short closure periods may not allow sufficient time for viral clearance. Extend closure if testing indicates ongoing shedding.
Genetic or management changes: Introduction of new genetics or changes in management practices can destabilize a stabilized herd. Monitor production parameters after any changes.
Welfare and Safety Context
PRRS virus infection causes significant animal welfare concerns through respiratory distress, reproductive failure, and increased mortality. The World Organisation for Animal Health recognizes the importance of animal welfare in disease control programs.
Welfare Implications
Respiratory distress: Pigs with PRRS-associated pneumonia experience dyspnea, tachypnea, and reduced activity. Severe cases may require euthanasia for humane reasons.
Reproductive failure: Abortions, stillbirths, and weak piglets cause suffering to both sows and piglets. Sows with dystocia or retained fetuses require veterinary attention.
Increased mortality: PRRS outbreaks can cause mortality rates of 10-20% in nursery pigs and 5-10% in breeding animals. Timely euthanasia of moribund animals is essential.
Secondary infections: PRRS-induced immunosuppression leads to increased bacterial infections, which cause additional pain and suffering. Prompt diagnosis and treatment of secondary infections improves welfare.
Safety Considerations
Vaccine safety: MLV vaccines can cause viremia and, rarely, disease in vaccinated animals. Follow label instructions and monitor for adverse reactions.
Needle safety: Needlestick injuries can transmit PRRS virus and other pathogens to personnel. Use proper needle handling and disposal protocols.
Chemical safety: Disinfectants and other chemicals used in biosecurity protocols can be hazardous. Follow safety data sheets and use appropriate personal protective equipment.
Zoonotic potential: PRRS virus is not considered zoonotic, but other pathogens in swine may be. Standard hygiene and biosecurity practices protect personnel.
Professional Escalation Criteria
Veterinarians should seek specialist consultation or escalate to regulatory authorities when:
- PRRS outbreak is suspected in a previously negative region
- Outbreak severity exceeds local capacity for management
- Novel or highly pathogenic strains are identified
- Elimination efforts are unsuccessful after 12 months
- Regulatory reporting is required by local or national authorities
- Public health concerns arise from secondary infections
Practical Decision Framework for PRRS Intervention Selection
Selecting the appropriate intervention for a PRRS-affected herd requires a structured decision process that accounts for herd status, production system constraints, economic factors, and available resources. Veterinarians often face multiple viable options, and the wrong choice can prolong losses or waste resources. This section provides a practical decision framework based on published veterinary literature and field experience.
Herd Classification and Intervention Mapping
The first step in intervention selection is accurate classification of the herd's PRRS status. The Merck Veterinary Manual describes four general herd categories: naive (negative, susceptible), unstable (acute outbreak or endemic with clinical disease), stable (virus present but no clinical disease), and negative (virus absent). Each category requires a different intervention approach.
Naive herds that experience a PRRS introduction require immediate action to contain the outbreak and prevent widespread infection. Options include emergency vaccination with modified-live virus (MLV) vaccine, strict quarantine of affected groups, and enhanced biosecurity. The World Organisation for Animal Health recommends rapid diagnostic confirmation before initiating control measures in previously negative populations.
Unstable herds with active clinical disease need interventions that reduce viral load, stabilize the breeding herd, and protect growing pigs. Herd closure combined with whole-herd MLV vaccination is a common approach. The duration of instability and severity of clinical signs determine whether closure alone is sufficient or whether depopulation should be considered.
Stable herds that are virus-positive but clinically normal require maintenance interventions to prevent destabilization. Ongoing vaccination, biosecurity monitoring, and periodic testing are appropriate. The goal is to maintain stability while working toward elimination if resources permit.
Negative herds require prevention-focused interventions including strict biosecurity, quarantine protocols for incoming stock, and surveillance testing. Vaccination is typically not used in negative herds because MLV vaccines can introduce live virus.
Decision Matrix for Breeding Herd Interventions
The following decision matrix helps veterinarians select interventions based on herd size, production system, and economic constraints. This framework is derived from published elimination strategies described in the veterinary literature.
| Herd Size | Production System | Clinical Severity | Recommended Intervention | Expected Timeline |
|---|---|---|---|---|
| Small (<500 sows) | Farrow-to-wean | Severe reproductive losses | Herd closure with MLV vaccination | 16-24 weeks |
| Small (<500 sows) | Farrow-to-wean | Mild clinical signs | Test and removal with vaccination | 8-16 weeks |
| Medium (500-2000 sows) | Farrow-to-wean | Severe outbreak | Herd closure with whole-herd MLV vaccination | 20-32 weeks |
| Medium (500-2000 sows) | Farrow-to-wean | Moderate signs | Herd closure with vaccination and partial depopulation | 24-36 weeks |
| Large (>2000 sows) | Multi-site | Severe outbreak | Herd closure with staged vaccination | 32-52 weeks |
| Large (>2000 sows) | Multi-site | Endemic with losses | Depopulation/repopulation or partial depopulation | 12-24 months |
| Any size | Farrow-to-finish | Severe respiratory disease | Flow management with nursery depopulation | 8-16 weeks |
The decision matrix should be adjusted based on local conditions, regulatory requirements, and available resources. The Merck Veterinary Manual notes that depopulation/repopulation is the most reliable method for PRRS elimination but is also the most expensive and disruptive.
Economic Analysis Framework
Before selecting an intervention, veterinarians should conduct a basic economic analysis comparing intervention costs with expected disease losses. The economic impact of PRRS includes direct losses from mortality, reduced growth, reproductive failure, and increased medication costs, as well as indirect losses from reduced genetic progress, labor costs, and market disruptions.
Cost components to estimate include:
- Mortality losses: Number of excess deaths multiplied by market value per pig
- Reproductive losses: Reduced farrowing rate, litter size, and weaned pigs per sow
- Growth losses: Reduced average daily gain and increased days to market
- Medication costs: Increased antimicrobial and supportive therapy expenses
- Labor costs: Additional time for vaccination, testing, and biosecurity
- Diagnostic costs: Testing for initial diagnosis and monitoring
- Vaccine costs: Product purchase and administration
- Genetic costs: Delayed genetic improvement during herd closure
Benefit components include:
- Reduced mortality and morbidity
- Improved reproductive performance
- Faster growth and improved feed efficiency
- Reduced medication costs
- Improved market access and pig value
- Reduced labor for disease management
The decision to intervene should be based on a positive cost-benefit ratio, typically targeting a return on investment of 3:1 or greater. The economic analysis should be updated as new information becomes available during the intervention.
Implementation Assessment Steps
Veterinarians should follow a systematic assessment process before implementing any PRRS intervention. The following steps provide a structured approach based on published protocols.
Step 1: Confirm diagnosis and characterize the virus
- Collect samples from acutely affected animals for PCR testing
- Sequence the virus (ORF5 or whole genome) to identify the strain
- Determine if the strain is homologous to available vaccine strains
- Assess for co-infections with other respiratory or reproductive pathogens
Step 2: Assess herd status and production parameters
- Review production records for the preceding 6-12 months
- Calculate baseline farrowing rate, abortion rate, litter size, and mortality
- Determine the stage of infection (acute outbreak, endemic, or stable)
- Identify high-risk groups (gilts, first-parity sows, nursery pigs)
Step 3: Evaluate biosecurity status
- Conduct a biosecurity audit using a standardized checklist
- Identify gaps in external and internal biosecurity
- Assess compliance with existing protocols
- Determine the most likely routes of virus introduction or spread
Step 4: Consider resource constraints
- Estimate available labor for vaccination and testing
- Determine budget for diagnostic testing and vaccines
- Assess facility limitations (quarantine space, isolation facilities)
- Evaluate genetic supply and replacement gilt availability
Step 5: Select intervention and develop timeline
- Use the decision matrix to identify appropriate options
- Discuss options with farm management and staff
- Develop a written protocol with specific timelines
- Assign responsibilities for each task
Step 6: Implement and monitor
- Begin intervention according to the protocol
- Monitor production parameters weekly
- Conduct diagnostic testing at predetermined intervals
- Adjust the protocol based on results
Step 7: Evaluate and modify
- Compare post-intervention production to baseline
- Assess whether goals are being met
- Identify barriers to success
- Modify the intervention as needed
Record System for Intervention Monitoring
A systematic record system is essential for tracking intervention progress and making data-driven decisions. The following record templates can be adapted for farm-specific use.
Weekly production monitoring record:
- Date and week of intervention
- Number of sows bred
- Farrowing rate (percentage)
- Abortion rate (percentage)
- Total born per litter
- Born alive per litter
- Stillborn per litter
- Mummies per litter
- Preweaning mortality (percentage)
- Nursery mortality (percentage)
- Average daily gain (grams/day)
- Feed conversion ratio
Diagnostic testing record:
- Date of sample collection
- Sample type (serum, oral fluid, tissue, semen)
- Number of samples collected
- Production stage sampled
- Test type (PCR, ELISA, sequencing)
- Laboratory name
- Test results (positive/negative, Ct value, S/P ratio)
- Interpretation
- Action taken
Vaccination record:
- Date of vaccination
- Vaccine product and lot number
- Route of administration
- Dose volume
- Target population
- Number of animals vaccinated
- Adverse reactions observed
- Staff member administering
Biosecurity compliance record:
- Date of audit
- Auditor name
- External biosecurity score (1-10)
- Internal biosecurity score (1-10)
- Identified deficiencies
- Corrective actions taken
- Completion date for corrective actions
Common Failure Patterns in Intervention Selection
Understanding why interventions fail helps veterinarians avoid common mistakes and improve success rates.
Failure to match intervention to herd status: Using a stabilization protocol in a naive herd during an acute outbreak may be too slow to prevent severe losses. Conversely, attempting elimination in an unstable herd without first achieving stabilization often fails. Always classify the herd before selecting an intervention.
Inadequate duration of intervention: Herd closure protocols that are too short allow persistent infection to continue. The Merck Veterinary Manual notes that closure periods of 16-32 weeks are typically required, with larger herds needing longer periods. Premature reopening is a common cause of elimination failure.
Poor compliance with protocols: Vaccination protocols that are not followed precisely, biosecurity measures that are inconsistently applied, and testing schedules that are missed all reduce intervention effectiveness. Regular training and monitoring of staff compliance is essential.
Failure to address co-infections: PRRS virus infection is often complicated by other pathogens such as Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, and Streptococcus suis. Managing PRRS without addressing concurrent infections leads to continued clinical disease even if PRRS virus is controlled.
Inadequate biosecurity during intervention: Introducing new animals, allowing contaminated transport, or failing to maintain quarantine during an intervention can reintroduce virus and negate progress. Biosecurity must be maintained throughout the intervention period.
Economic constraints limiting intervention scope: Budget limitations may lead to incomplete vaccination, insufficient testing, or shortened closure periods. Veterinarians should advocate for adequate resources based on the expected return on investment.
Professional Escalation Criteria
Veterinarians should seek specialist consultation or escalate to regulatory authorities when:
- The PRRS outbreak involves a novel or highly pathogenic strain
- The outbreak occurs in a region with official PRRS control programs
- Intervention efforts fail to achieve stabilization after 12 months
- Mortality rates exceed 15% in nursery pigs or 5% in breeding animals
- Secondary infections become unmanageable with standard protocols
- Regulatory reporting is required by local or national authorities
- The herd is part of a regional elimination program
The World Organisation for Animal Health provides guidance on reporting requirements and control measures for PRRS in member countries. Veterinarians should be familiar with local regulations and reporting obligations.
Frequently Asked Questions
What is the difference between PRRS Type 1 and Type 2 viruses?
PRRS virus is classified into two genotypes: Type 1 (European) and Type 2 (North American). Type 1 strains are more common in Europe and Asia, while Type 2 strains predominate in North America and parts of Asia. The two genotypes share approximately 60% nucleotide identity and produce similar clinical disease, but they are antigenically distinct. Diagnostic tests can differentiate between genotypes, and vaccines are typically genotype-specific. Cross-protection between genotypes is limited.
How long does PRRS virus survive in the environment?
PRRS virus survival depends on temperature, humidity, and surface type. The virus can survive for several days to weeks in cool, moist conditions but is rapidly inactivated by heat, drying, and sunlight. PRRS virus can survive in manure for several days, in water for up to 11 days, and on surfaces for 1-7 days depending on conditions. The virus is susceptible to most common disinfectants, including bleach, quaternary ammonium compounds, and peroxygen compounds.
Can PRRS be transmitted through semen?
Yes, PRRS virus can be shed in semen from infected boars. Boars can shed virus in semen for 2-4 weeks after infection, and some boars may shed intermittently for longer periods. Semen testing by PCR is recommended for boar studs, and positive samples should not be used for breeding. Artificial insemination with contaminated semen can introduce PRRS virus into naive herds.
What is the role of maternal antibodies in PRRS protection?
Maternal antibodies from immune sows provide passive protection to piglets during the first 4-8 weeks of life. These antibodies reduce the severity of PRRS virus infection but do not prevent infection entirely. Maternal antibodies can interfere with vaccination, so timing of piglet vaccination must account for antibody levels. Piglets from naive sows are fully susceptible to PRRS virus from birth.
How is PRRS eliminated from a breeding herd?
PRRS elimination from breeding herds can be achieved through several methods, including herd closure, depopulation/repopulation, and test and removal. Herd closure involves stopping introduction of new breeding stock for 16-32 weeks while the existing herd develops immunity and clears the virus. Depopulation/repopulation removes all pigs and restocks with PRRS-negative animals. Test and removal identifies and culls persistently infected animals. The choice of method depends on herd size, resources, and production goals.
What is the economic impact of PRRS on swine production?
PRRS causes significant economic losses through reduced reproductive performance, increased mortality, decreased growth rates, and increased medication costs. The Merck Veterinary Manual notes that PRRS is one of the most economically important diseases of swine. Economic losses vary by herd and outbreak severity but can be substantial, particularly in breeding herds and nursery populations.
Can PRRS be prevented through genetic selection?
Research is ongoing to identify genetic resistance to PRRS virus infection. Studies have identified genetic markers associated with reduced susceptibility and improved immune response. The CD163 receptor is required for PRRS virus entry into cells, and genetically modified pigs with CD163 mutations have shown resistance to infection. However, genetically resistant pigs are not yet commercially available, and genetic selection alone is not sufficient for PRRS control.
What is the difference between PRRS stabilization and elimination?
Stabilization refers to achieving a state where PRRS virus is no longer causing clinical disease in the herd, but the virus may still be present and circulating at low levels. Elimination refers to complete removal of PRRS virus from the herd, resulting in a PRRS-negative status. Stabilization is often the first step in PRRS control, followed by elimination if resources and goals permit. Stabilized herds have reduced production losses but remain at risk for outbreaks if biosecurity fails.
Related Veterinary Guides
- Swine Respiratory Disease Observation And Diagnostics
- Manure Management For Pig Farms
- Herd Data Management Swine Production Records Analysis
- Pig Lameness Monitoring And Flooring Management
- Veterinary Clinical Methods Procedures Surgical Interventions
References and Further Reading
- World Organisation for Animal Health
- Merck Veterinary Manual. Merck Veterinary Manual.
- Animal Health and Welfare. World Organisation for Animal Health.
- Diagnosis of PRRS.. Veterinary microbiology, 1997.
- Multi-Omics Analysis by Machine Learning Identified Lysophosphatidic Acid as a Biomarker and Therapeutic Target for Porcine Reproductive and Respiratory Syndrome.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024.
- Boehringer Ingelheim: VR-Video zeigt Zerstörungskraft des PRRS-Virus in der Schweinelunge.. Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere, 2018.
- Porcine reproductive and respiratory syndrome.. Veterinary pathology, 1998.
- Genetically modified pigs with CD163 point mutation are resistant to HP-PRRSV infection.. Zoological research, 2024.
- Alternative strategies for the control and elimination of PRRS.. Veterinary microbiology, 2017.
- Effect of orally administered Lactobacillus casei on porcine reproductive and respiratory syndrome (PRRS) virus vaccination in pigs. Veterinary Microbiology, 2007.
- DNA vaccination of pigs with open reading frame 1-7 of PRRS virus. Vaccine, 2004.
- An integrated epidemiological and economic analysis of vaccination against highly pathogenic porcine reproductive and respiratory syndrome (PRRS) in Thua Thien Hue Province, Vietnam. Asian Australasian Journal of Animal Sciences, 2014.
- Assessment of immediate production impact following attenuated PRRS type 2 virus vaccination in swine breeding herds. Porcine Health Management, 2019.
- The effect of vaccination of sows against PRRS: The results of questionnaires. Tijdschrift Voor Diergeneeskunde, 1999.
This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.